Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional)

Funder: National Institutes of Health

Due Date: 3/19/2018

Budget: $2,000,000

Opportunity: RFA-AT-18-003

Evidence is building that low molecular weight compounds, derived from interaction of dietary constituents and other natural products with the gut microbiome, have important biological activity. The purpose of this Funding Opportunity Announcement (FOA), therefore, is to identify metabolites produced by the interaction between commensal bacteria and dietary phytochemicals and characterize their biological activity.  This FOA will support both model systems research, and mechanistic clinical studies.

Leave a Reply